【24h】

Peritoneal dialysis in Croatia.

机译:克罗地亚的腹膜透析。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To present the state of renal replacement therapy (RRT) in Croatia, assess the quality of dialytic treatment, verify the value of peritoneal dialysis (PD), and promote expansion of PD in Croatia based on results attained locally. According to the integrative care concept, PD is the best way to start life-long RRT. Croatian nephrologists have adopted the policy of increasing the use of PD. However, evidence for recommendations were obtained in specific circumstances and might not be relevant elsewhere. The aim of this observational study is to compare the outcome of PD with that of hemodialysis (HD), as practiced in Croatia. METHODS: Since 2000, the Croatian Registry for Renal Replacement Therapy has been collecting individual patient data for all patients on RRT, with complete coverage. RESULTS: As of 31 December 2004, there were 251 prevalent patients on PD (continuous ambulatory PD and automated PD) in Croatia, accounting for 7% of all patients on RRT and giving a prevalence of 57 patientsper million population. From 1 January 2000 to 31 December 2004, 377 patients started PD and were followed from the first day of RRT. For 80% of them, PD was the first mode of RRT. The probability of staying on PD for 5 years was 31% [95% confidence interval (CI) 29-32]. Five-year technique survival (excluding transplanted, recovered, and deceased patients) was 68% (95%CI 65-70). For survival analysis and comparison between PD and HD, only patients on the same method from the start of their RRT were included. Patients changing treatment were censored after 60 days (intention-to-treat analysis). Unadjusted 5-year survival in the PD-first group (301 patients) was 60% (95%CI 54-65), which is significantly better than in the 2789 HD-first patients (42%, 95%CI 40-44; log-rank p < 0.0001). When data were stratified for age and diabetes, 5-year mortality rates on HD were higher in all strata. Only in patients >/=70 years old was the advantage of PD less impressive. Standardized mortality ratio was 1.85 (p < 0.01) infavor of PD. Hazard ratio of HD versus PD was 2.1 (95%CI 1.6-2.8). After adjustments for age, gender, diabetes, and nephroangiosclerosis, the hazard ratio settled at 1.5 (95%CI 1.1-1.9). CONCLUSION: In Croatia, PD is used mostly as the first RRT. Almost one third of patients continue PD for 5 years due to good patient and technique survival. Starting RRT with PD offers 50% superior 5-year survival in comparison to HD. Dialysis patients in Croatia would benefit from an expanded PD program.
机译:目的:根据当地获得的结果,介绍克罗地亚的肾脏替代疗法(RRT)的状态,评估透析治疗的质量,验证腹膜透析(PD)的价值并促进PD的扩展。根据综合护理概念,PD是启动终生RRT的最佳方法。克罗地亚肾脏病学家采取了增加PD使用的政策。但是,建议的证据是在特定情况下获得的,可能与其他地方无关。这项观察性研究的目的是按照克罗地亚的实践比较PD与血液透析(HD)的结果。方法:自2000年以来,克罗地亚肾脏替代治疗注册局一直在为RRT的所有患者收集单独的患者数据,并全面覆盖。结果:截至2004年12月31日,克罗地亚有251例PD(连续非卧床PD和自动PD)患病患者,占所有RRT患者的7%,每百万人口中有57例患病率。从2000年1月1日至2004年12月31日,有377例患者开始PD,并从RRT的第一天开始随访。对于其中的80%,PD是RRT的第一模式。保持PD五年的可能性为31%[95%置信区间(CI)29-32]。五年技术生存率(不包括移植,康复和死者)为68%(95%CI 65-70)。为了进行生存分析以及PD和HD之间的比较,仅包括从RRT开始就采用相同方法的患者。改变治疗的患者在60天后接受检查(意向治疗分析)。 PD-first组(301例患者)的未经调整的5年生存率为60%(95%CI 54-65),明显好于2789 HD-first组(42%,95%CI 40-44; 2%,95%CI 40-44)。对数秩p <0.0001)。当对年龄和糖尿病进行分层时,所有阶层的HD 5年死亡率均较高。仅在> / = 70岁的患者中,PD的优势不那么令人印象深刻。 PD的标准死亡率为1.85(p <0.01)。 HD与PD的危险比为2.1(95%CI 1.6-2.8)。在调整了年龄,性别,糖尿病和肾血管硬化后,危险比定为1.5(95%CI 1.1-1.9)。结论:在克罗地亚,局部放电主要用作第一个RRT。由于良好的患者和技术存活率,近三分之一的患者会继续PD五年。与HD相比,从PD开始RRT可提供50%的优越5年生存率。克罗地亚的透析患者将从扩展的PD计划中受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号